Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
If you experience side effects like dizziness, it is advisable to limit alcohol intake
The analysis integrates findings from preclinical investigations, limited clinical data, and regulatory perspectives
is based on real changes in your body, not symptoms alone
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
